Sector: Health Care
Director information for CELLDEX THERAPEUTICS INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Anthony S. Marucci | Founder, President and CEO; President, Chief Executive Officer and Director | 64 | ["Former Vice President, Chief Financial Officer, Treasurer and Secretary","M.B.A. from Columbia University","M.H.L. from Brown University","Board of directors at Genenta Science S.p.A. from May 2021 to April 2024","Board of Trustees at BioNJ Inc.","Former Vice President, Chief Financial Officer, Treasurer and Secretary at Celldex","Treasurer at Medarex"] | [] | 2026 |
| Cheryl L. Cohen | Director | 60 | ["President of CLC Consulting since 2008","Chief Commercial Officer at Medivation, Inc. from August 2011 to July 2014","Former Vice President of the Rheumatology Franchise at Johnson & Johnson","Former management and sales at Solvay Pharmaceuticals"] | ["Compensation and Organization Development","Science and Commercialization"] | 2026 |
| Denice Torres | Director | 66 | ["Chief Executive Officer of The Ignited Company since 2017","Chief Strategy and Transformation Officer at Johnson & Johnson from 2015 to 2017","President at Johnson & Johnson McNeil Consumer Healthcare from 2011 to 2015","President at Johnson & Johnson Janssen Pharmaceuticals, Neuroscience from 2009 to 2011","Various Executive Positions at Eli Lilly and Company from 1990 to 2004","Board of directors at 2seventybio from 2021 to 2025","Board of directors at Glaukos Corporation since 2021","Board of directors at Karuna Therapeutics, Inc. from 2020 to 2024","Board of directors at Surface Oncology from 2021 to 2023","Board of directors at Bluebird bio, Inc. from 2020 to 2021"] | ["Compensation and Organization Development","Science and Commercialization"] | 2026 |
| Garry A. Neil, M.D. | Director | 72 | ["Chief Executive Officer at Avalo Therapeutics since February 2022","Chairman of the Board at Avalo Therapeutics from August 2022 to March 2025","Senior Scientific Adviser and Chief Scientific Officer from February 2020 to February 2022","Former Chief Scientific Officer at Avalo Therapeutics from September 2013 to February 2020","Corporate Vice President of Science & Technology at Johnson & Johnson from November 2007 to August 2012","Former Group President at Johnson & Johnson Pharmaceutical Research and Development","Former Vice President of Research & Development at Merck KGaA/EMD Pharmaceuticals","Former Vice President of Clinical Research at AstraZeneca and Astra Merck","Board of directors at Arena Pharmaceuticals, Inc. since February 2017","Chair at Arena Pharmaceuticals, Inc. since February 2021","Former board member at Zura Bio Limited from March 2023 to November 2023","Former board member at GTx, Inc. from August 2016 to May 2019","Board of the Center for Discovery and Innovation at Hackensack Meridian Medical School","Founding Chairman and past member of the board at TransCelerate Biopharma, Inc. from 2012 to 2019","Former board member at Reagan Udall Foundation for the FDA from 2007 to 2021","Former board member at National Institutes of Health from 2010 to 2012","Former Chairman of Science and Regulatory Executive Committee and the PhRMA Foundation Board"] | ["Audit","Nominating and Corporate Governance"] | 2026 |
| Harry H. Penner, Jr. | Director; Chair | 80 | ["Chairman and Chief Executive Officer of Nascent BioScience, LLC from 2001 to June 2023","President, Chief Executive Officer and Vice Chairman of Neurogen Corporation from 1993 to 2001","Executive Vice President and General Counsel of Novo Nordisk A/S in Denmark from 1985 to 1988","Executive Vice President for North America of Novo Nordisk A/S from 1988 to 1993","Former Chair of BioCT","Former BioScience Advisor to the Governor and the State of Connecticut","Former Chair of Connecticut Technology Council","Former Chair of Connecticut Board of Governors of Higher Education","Currently Chair of NeuroCyte Therapeutics, Inc."] | [] | 2026 |
| Herbert J. Conrad | Director | 93 | ["President of the U.S. Pharmaceuticals Division from 1982 to 1993","Former director at Matinas BioPharma Holdings, Inc.","Advisor at Seaver Autism Center at Mount Sinai Hospital","B.S. and M.S. degrees from the Brooklyn College of Pharmacy","Honorary Doctorate in Humane Letters from Long Island University","Former Chairman of the Board of Directors at Pharmasset, Inc.","Former director at GenVec, Inc.","Former director at Bone Care International, Inc.","Former director at Arbutus Biopharma Corporation","Former director and co-founder at Reliant Pharmaceuticals, Inc."] | ["Nominating and Corporate Governance"] | 2026 |
| James J. Marino | Director | 76 | ["Former Partner at Dechert LLP","Managing Partner of the Princeton Office","Chair of Life Science practice","Former director at Traws Pharma, Inc.","Former Chairman of the Board at Traws Pharma, Inc.","Former director at Pharmacopeia Inc.","Co-founder and former counsel of BioNJ Inc.","Life Trustee at Wake Forest University"] | ["Audit","Compensation and Organization Development"] | 2026 |
| Keith L. Brownlie | Director | 73 | ["Former Audit partner for numerous public companies","Life Sciences Industry Leader for the New York Metro Area until 2009","B.S. in Accounting from Lehigh University","Certified Public Accountant"] | ["Audit"] | 2026 |
| Rita I. Jain, M.D. | Director | 64 | ["B.S. degree in biology from Long Island University","M.D. from the State University of New York at Stony Brook School of Medicine","Executive Vice President and Chief Medical Officer at ChemoCentryx, Inc. from 2021 to 2022","Chief Medical Officer at Immunovant, Inc. in 2021","Chief Executive Officer at Heartwood Biopharma Group from August 2021 until December 2023","Senior Vice President and Chief Medical Officer at Akebia Therapeutics, Inc. from 2017 to 2019","Vice President in Clinical Development at AbbVie Inc. from 2013 to 2016"] | ["Nominating and Corporate Governance","Science and Commercialization"] | 2026 |
| Tibor Keler | 67 | ["Ph.D. in Microbiology from the University of Pennsylvania","Senior Vice President and Chief Scientific Officer at Celldex from March 2008 to July 2014","Vice President, Research and Discovery and Chief Scientific Officer from May 2003 to March 2008","Senior Director of Preclinical Development and Principal Scientist at Medarex from September 1993 to March 2004"] | [] | 2026 |
